Somatostatin expression in TS16 mouse brain cultures

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Trisomy 16 in mice serves as a model for Down syndrome.
• Gene dosage effects on neuropeptide expression are not fully understood.
• Somatostatin (SS) plays crucial roles in neuronal function.

Purpose of the Study:

• To investigate the impact of an extra copy of the pre-pro-somatostatin (ppSS) gene on SS expression in trisomy 16 mouse neuronal cultures.
• To determine if trisomy 16 affects the expression of other neuropeptides not located on chromosome 16.
• To analyze the influence of glial cells on SS phenotype in trisomic neurons.

Main Methods:

• Primary neuronal and glial cultures from trisomy 16 and control mice.
• Quantitative analysis of ppSS and pre-pro-neuropeptide Y (ppNPY) mRNA expression using RT-PCR.
• Immunoreactivity assessment for SS, neuropeptide Y, glutamic acid decarboxylase, and gamma-enolase.
• Morphometrical analysis of SS-positive neurons.

Main Results:

• Trisomy 16 cultures showed significantly increased ppSS mRNA levels compared to controls.
• Expression of other neuropeptides (NPY, GAD, gamma-enolase) remained unchanged.
• Neuron-enriched cultures from trisomic mice had fewer SS-positive neurons than mixed cultures, normalizing SS-positive neuron counts between trisomic and control groups.

Conclusions:

• An extra copy of the ppSS gene upregulates its mRNA transcript in trisomy 16 mouse neuronal cultures.
• The peptidergic phenotype of somatostatin is modulated by the presence of neuroglial cells.
• Glial-neuronal interactions are critical for determining somatostatin expression levels in the nervous system.